UBS O'Connor’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-105,108
| Closed | -$302K | – | 353 |
|
|
2024
Q4 | $302K | Sell |
105,108
-60,000
| -36% | -$173K | 0.01% | 292 |
|
|
2024
Q3 | $424K | Buy |
165,108
+15,336
| +10% | +$39.4K | 0.01% | 338 |
|
|
2024
Q2 | $294K | Buy |
149,772
+42,360
| +39% | +$83K | 0.01% | 380 |
|
|
2024
Q1 | $286K | Sell |
107,412
-36,177
| -25% | -$96.2K | 0.01% | 358 |
|
|
2023
Q4 | $595K | Sell |
143,589
-75,845
| -35% | -$314K | 0.02% | 323 |
|
|
2023
Q3 | $303K | Buy |
219,434
+80,000
| +57% | +$110K | 0.01% | 414 |
|
|
2023
Q2 | $436K | Buy |
139,434
+34,565
| +33% | +$108K | 0.01% | 441 |
|
|
2023
Q1 | $357K | Buy |
+104,869
| New | +$357K | 0.01% | 476 |
|